To include your compound in the COVID-19 Resource Center, submit it here.

GS 9256: Additional Phase IIa data

Additional data from the open-label, international Phase IIa Study 196-0112 trial in 42 treatment-naïve patients with HCV genotype 1 infection showed that dual therapy with twice-daily

Read the full 268 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE